Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial
Crossref DOI link: https://doi.org/10.1007/s40268-015-0104-x
Published Online: 2015-08-19
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ambery, Claire L.
Wielders, Pascal
Ludwig-Sengpiel, Andrea
Chan, Robert
Riley, John H.
Funding for this research was provided by:
GlaxoSmithKline (GB)
License valid from 2015-08-19